When was Paradigm Health founded?

Paradigm Health was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is Paradigm Health located?

Paradigm Health is headquartered in Columbus, United States.

Who is the current CEO of Paradigm Health?

Karen Knudsen and Kent Thoelke s of Paradigm Health.

Is Paradigm Health a funded company?

Paradigm Health is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Dec 04, 2025.

When was the latest funding round of Paradigm Health?

Paradigm Health's latest funding was a $***** Series B round on Dec 04, 2025, with participation from 8 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.44B in funding in 2026 to date.

Where does Paradigm Health rank among its competitors?

Paradigm Health ranks 38th amongst 316 active competitors, of which 54 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Tempus, which secured $460M in Jul, 2026.

Who are the top competitors of Paradigm Health?

Paradigm Health's top competitors include Medidata, Verily and IQVIA. Among them, Tempus secured the most recent funding round in July, 2026.

Paradigm Health - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a platform to re-engineer clinical trials around patient care. The platform helps stakeholders connect and overcome complexities in the clinical trial journey. It combines technology and services, integrating with health provider organizations to fuel collaboration. The platform aims to break down barriers across the trial ecosystem through infrastructure implemented at healthcare provider organizations.

Key Metrics

Founded Year

2021

Location

Columbus, United States

Stage

Series B

Total Funding

$78M in 1 round

Latest Funding Round

Series B, Dec 04, 2025, $*****

Investors

Arch Venture Partners & 7 more

Ranked

38^th among 316 active competitors

Similar Companies

Medidata & 359 more

View Paradigm Health's full profile

Paradigm Health has raised a total funding of $78M over 1 round. Its latest funding round was a Series B round on Dec 04, 2025 for $*****. 8 investors participated in its latest round. Paradigm Health has 8 institutional investors.

Here is the list of recent funding rounds of Paradigm Health:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 04, 2025	6479258	Series B	9639198	9783061	6517509	8480252

Access funding benchmarks and valuations. Sign up today!

View details of Paradigm Health's funding rounds and investors

The founders of Paradigm Health is Robert Nelsen.

Here are the details of Paradigm Health's key team members:

Robert Nelsen: Co-Founder & Managing Director, ARCH Venture Partners of Paradigm Health.
Karen Knudsen: CEO of Paradigm Health.
Kent Thoelke: CEO of Paradigm Health.
Contact Info: 1 email address

View details of Paradigm Health's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Paradigm Health include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Paradigm Health, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	79/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	73/100
7th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, F2 Ventures ... & 6 others	66/100
8th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Ares Capital Corporation, Prospect Capital ... & 6 others	64/100
9th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, DHVC & 17 others	63/100
10th	Obvio Health 2015, Orlando (United States), Series B	Provider of clinical trials design and recruitment platform	$66M	Dedalus Group, Guardant Health & 13 others	62/100
38th	Paradigm Health 2021, Columbus (United States), Series B	Provider of a platform to re-engineer clinical trials around patient care	$78M	Mubadala, DFJ Growth & 6 others	44/100